Loading the section…
Closing prices for 9 October 2026
Next earnings report: 29 October 2026 · Earnings calendar
Change over the period shown (line colour): −52.09 %
The series is stated in the current share scale after splits; dividends are not included in the price
No events for this security recently.
Address:BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, CB21 6GS, GB
Bicycle Therapeutics plc trades on Nasdaq under the ticker BCYC. The company belongs to the Health care sector. The trading history on this page starts on 23 May 2019.
Over the past 52 weeks BCYC has traded between 3.33 $ and 9.16 $. As of 9 October 2026 the price stood 9.61 % of the way from the 52-week low to the high.
Over one year BCYC shares fell 52.91 %; over six months they fell 21.26 %. Volatility over 90 days is 48.69 %. Dividends are not included: this is price change only, as of 9 October 2026.
Bicycle Therapeutics plc reported revenue of 63M $ and a net loss of 219M $ over the last four quarters. Net margin is −344.95 %. Revenue changed by +146.85 % year over year. Earnings per share are −3.15 $.
BCYC has a return on equity of −39.51 %, above the sector median of −41.68 %. Return on assets is −33.57 %, below the sector median of −32.11 %. Operating margin is −381.67 %, below the sector median of −26.84 %.
| Security | Price, $ | Day change | Turnover 30d, $ |
|---|---|---|---|
| GSKGSK plc | 46.50 | −0.09 % | 190M |
| ONCBeOne Medicines Ltd. | 354.47 | +1.24 % | 135M |
| ABVXAbivax SA | 88.15 | −1.01 % | 135M |
| SNYSanofi | 40.07 | −0.40 % | 115M |
| GMABGenmab A/S | 37.07 | +2.83 % | 111M |
| GPCRStructure Therapeutics Inc. | 25.54 | −0.51 % | 49M |
| LEGNLegend Biotech Corporation | 18.62 | −0.48 % | 40M |
| BLTEBelite Bio, Inc | 154.49 | +1.29 % | 34M |
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 3.81 | 3.92 | 3.78 | 3.89 | 300,600 |
| 8 October 2026 | 3.71 | 3.81 | 3.62 | 3.81 | 337,700 |
| 7 October 2026 | 3.75 | 3.81 | 3.68 | 3.73 | 472,600 |
| 6 October 2026 | 4.02 | 4.03 | 3.74 | 3.79 | 620,700 |
| 5 October 2026 | 3.62 | 4.04 | 3.61 | 4.01 | 2M |
| 2 October 2026 | 3.65 | 3.70 | 3.33 | 3.38 | 728,700 |
| 1 October 2026 | 3.67 | 3.74 | 3.55 | 3.56 | 379,900 |
| 30 September 2026 | 3.69 | 3.77 | 3.66 | 3.68 | 295,100 |
| 29 September 2026 | 3.72 | 3.77 | 3.64 | 3.65 | 206,200 |
| 28 September 2026 | 3.69 | 3.81 | 3.58 | 3.71 | 442,500 |
| 25 September 2026 | 3.73 | 3.73 | 3.65 | 3.69 | 238,900 |
| 24 September 2026 | 3.66 | 3.95 | 3.66 | 3.73 | 820,000 |
| 23 September 2026 | 3.72 | 3.72 | 3.57 | 3.60 | 374,200 |
| 22 September 2026 | 3.67 | 3.83 | 3.65 | 3.73 | 554,700 |
| 21 September 2026 | 3.70 | 3.77 | 3.63 | 3.63 | 266,500 |
| 18 September 2026 | 3.69 | 3.70 | 3.63 | 3.65 | 240,400 |
| 17 September 2026 | 3.73 | 3.79 | 3.67 | 3.68 | 185,100 |
| 16 September 2026 | 3.68 | 3.73 | 3.61 | 3.64 | 599,900 |
| 15 September 2026 | 3.88 | 3.90 | 3.65 | 3.67 | 544,100 |
| 14 September 2026 | 3.90 | 3.95 | 3.83 | 3.89 | 209,400 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.